- Home
- XAIR vs TXMD Comparison
XAIR vs TXMD Comparison
Compare XAIR & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XAIR
- TXMD
- Stock Information
- Founded
- XAIR 2011
- TXMD 2008
- Country
- XAIR United States
- TXMD United States
- Employees
- XAIR N/A
- TXMD N/A
- Industry
- XAIR Medical/Dental Instruments
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- XAIR Health Care
- TXMD Health Care
- Exchange
- XAIR Nasdaq
- TXMD Nasdaq
- Market Cap
- XAIR 17.0M
- TXMD 13.9M
- IPO Year
- XAIR N/A
- TXMD N/A
- Fundamental
- Price
- XAIR $2.86
- TXMD $1.11
- Analyst Decision
- XAIR Strong Buy
- TXMD
- Analyst Count
- XAIR 3
- TXMD 0
- Target Price
- XAIR $23.67
- TXMD N/A
- AVG Volume (30 Days)
- XAIR 386.6K
- TXMD 24.3K
- Earning Date
- XAIR 08-12-2025
- TXMD 08-08-2025
- Dividend Yield
- XAIR N/A
- TXMD N/A
- EPS Growth
- XAIR N/A
- TXMD N/A
- EPS
- XAIR N/A
- TXMD N/A
- Revenue
- XAIR $3,705,000.00
- TXMD $1,841,000.00
- Revenue This Year
- XAIR $266.61
- TXMD $427.09
- Revenue Next Year
- XAIR $140.76
- TXMD N/A
- P/E Ratio
- XAIR N/A
- TXMD N/A
- Revenue Growth
- XAIR 219.67
- TXMD 53.55
- 52 Week Low
- XAIR $2.75
- TXMD $0.70
- 52 Week High
- XAIR $13.52
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- XAIR 37.13
- TXMD 42.16
- Support Level
- XAIR $2.93
- TXMD $1.12
- Resistance Level
- XAIR $3.78
- TXMD $1.21
- Average True Range (ATR)
- XAIR 0.26
- TXMD 0.06
- MACD
- XAIR -0.03
- TXMD -0.00
- Stochastic Oscillator
- XAIR 8.91
- TXMD 25.00
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.